Archive for 'M&A'
Protherics Biotech talking with Potential Buyers
Situation Analysis: Shares of the UK’s Protherics surged more than 30 percent after the biotech announced that “a number of parties” have expressed an interest in buying the company. Rumors about a possible buyout had already triggered a rise in share value, which prompted the statement.
Protherics recently launched a Phase IIa trial for its Angiotensin […]
Posted: August 14th, 2008 under Financial Management, M&A, Management, Pharma_Biotech, R&D.
Comments: none
Avalon Pharma Cuts Staff as It Scrambles to Raise Cash
Options for Avalon’s Board
Best Option: Raise debt capital, pledging whatever assets it can, and use that for two purposes:
(a) do the biotech drug development with a strict performance based incremental investment
(b) start a service based revenue stream that can generate some operating cash.
Avalon Board and CXOs have to figure out what services they can offer […]
Posted: August 14th, 2008 under Business Plan, Business Strategy, Financial Management, M&A, Management, People & Teams, Pharma_Biotech, R&D, Venture Capital.
Comments: none
Telecom Industry Update & Powerwave Technologies Analysis
Mobile operator messaging revenues are under threat. Operators are rolling out flat rate data packages to encourage mobile Internet usage and uptake, which is in turn enabling the availability of free, ad-funded online messaging on the mobile handset. Mobile application development is by nature technically challenging. However, the carriers have not helped. Mobile technologies are […]
Posted: July 18th, 2008 under Industry Trends, M&A, Management, Sales & Marketing, Telecom.
Comments: none